Cancer evolution
Genomic aberrations in the FGFR pathway
Factors influencing adherence to cancer treatment in older adults with cancer
Sporadic desmoid-type fibromatosis
Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials
Characteristics and clinical outcome of T1 breast cancer
The impact of adjuvant radiotherapy on the survival of primary breast cancer patients
An internally and externally validated prognostic score for metastatic breast cancer
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients
The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer
Metastatic pattern in colorectal cancer is strongly influenced by histological subtype
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
The role of body mass index in survival outcome for lymphoma patients
On-going clinical trials for elderly patients with a hematological malignancy
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma
Breaking bad news–what patients want and what they get
Plasma testosterone in the general population, cancer prognosis and cancer risk
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas
Effect of marital status on treatment and survival of extremity soft tissue sarcoma
Retroperitoneal sarcomas
Retroperitoneal sarcomas
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021)
Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma
Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer—a problem still to be solved
Reply to
Parameningeal rhabdomyosarcoma in pediatric age
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer